kca 098 and coumestrol
kca 098 has been researched along with coumestrol in 10 studies
Compound Research Comparison
| Studies (kca 098) | Trials (kca 098) | Recent Studies (post-2010) (kca 098) | Studies (coumestrol) | Trials (coumestrol) | Recent Studies (post-2010) (coumestrol) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 305 | 2 | 111 |
Protein Interaction Comparison
| Protein | Taxonomy | kca 098 (IC50) | coumestrol (IC50) |
|---|---|---|---|
| SUMO-1 | Homo sapiens (human) | 14.7 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 32.34 | |
| Estrogen receptor | Homo sapiens (human) | 0.0433 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 0.2 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 0.2 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 0.2 | |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | 0.2 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0131 |
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arai, N; Endo, H; Itoh, F; Kawashima, K; Kojima, M; Nagata, H; Tsutsumi, N; Tsuyuki, J; Ujiie, A | 1 |
| Endo, H; Itoh, F; Kawashima, K; Kojima, M; Nagata, H; Okazaki, M; Tsutsumi, N; Ujiie, A | 2 |
| Arai, N; Endo, H; Kawashima, K; Kojima, M; Nagata, H; Tsutsumi, N; Ujiie, A | 1 |
| Iizuka, K; Ikegami, K; Otagiri, M; Saito, N; Toda, M; Yamada, T | 1 |
| Endo, H; Inoue, T; Kawashima, K; Tsutsumi, N | 1 |
| Imai, T; Otagiri, M; Saito, N; Yamada, T | 1 |
| Fujioka, M; Imai, I; Miyagi, M; Otagiri, M; Saito, N; Yamada, T; Yamamoto, A | 1 |
| Hirayama, F; Imai, T; Otagiri, M; Ouchi, K; Uekama, K; Yamada, T | 1 |
| Anraku, M; Imai, T; Otagiri, M; Saito, N; Yamada, T | 1 |
Other Studies
10 other study(ies) available for kca 098 and coumestrol
| Article | Year |
|---|---|
Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Calcium; Calcium, Dietary; Chick Embryo; Coumestrol; Dinoprostone; Female; Femur; Interleukin-1; Isoflavones; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Wistar | 1994 |
Induction of osteopenia in confined rats.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Coumestrol; Disease Models, Animal; Immobilization; Male; Rats; Rats, Wistar | 1994 |
In vitro effect of KCA-098, a derivative of coumestrol, on bone resorption of fetal rat femurs.
Topics: Animals; Bone Resorption; Calcification, Physiologic; Calcium; Coumestrol; Estradiol; Female; Femur; Organ Culture Techniques; Organ Size; Ovariectomy; Parathyroid Hormone; Phosphorus; Pregnancy; Rats; Rats, Wistar; Uterus | 1994 |
Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism.
Topics: Animals; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcium; Chick Embryo; Coumestrol; Culture Techniques; Dose-Response Relationship, Drug; Female; Femur; Ovariectomy; Phosphorus; Rats; Rats, Wistar | 1994 |
[Polymorphism of 3,9-bis-(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2- c]quinoline-6-one(KCA-098), a new benzofuroquinoline derivative].
Topics: Chemical Phenomena; Chemistry, Physical; Coumestrol; Crystallization; Solubility; X-Ray Diffraction | 1995 |
Effect of KCA-098 on the function of osteoblast-like cells and the formation of TRAP-positive multinucleated cells in a mouse bone marrow cell population.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Marrow; Bone Resorption; Cell Division; Collagen; Coumestrol; Estradiol; Isoenzymes; Male; Mice; Osteoblasts; Osteocalcin; Structure-Activity Relationship; Tartrate-Resistant Acid Phosphatase | 1996 |
Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug.
Topics: Cellulose; Coumestrol; Drug Compounding; Particle Size; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 1999 |
Characterization of urinary metabolites of a new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), in dogs.
Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Coumestrol; Dealkylation; Dogs; Hydrolysis; Hydroxylation; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry | 1999 |
Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, Gas; Coumestrol; Cyclodextrins; Solubility; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; X-Ray Diffraction | 2000 |
Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion
Topics: Absorption; Animals; Cellulose; Coumestrol; Crystallization; Dogs; Male; Osteoporosis; Powders; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2000 |